# Holdings

> Holdings is a VC fund in Singapore backing Health Care and Health Diagnostics. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Singapore, Singapore
- Total investments: 4
- Last investment: Sep 2023
- Lead investor: 50%
- Last updated: Aug 2026
- Website: http://atcapital.com.sg/

Holdings is a VC fund in Singapore focused on Health Care and Health Diagnostics. The Group comprises AT Holdings, the asset owning company, and AT Capital, the in-house asset management entity.

## Contacts

5 contacts available for Holdings. Shizune tracks 1 team members at Holdings. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/at-capital-group?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 50% |
| Health Diagnostics | 2 | 50% |
| Solar | 1 | 25% |
| Credit | 1 | 25% |
| Energy | 1 | 25% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 50% |
| Series A | 1 | 25% |
| Funding Round | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 50% |
| India | 1 | 25% |
| Singapore | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Arvind Tiku | Founder & Group Chairman | 1 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Juniper Green Energy | Juniper Green Energy is an operator of solar, hybrid and wind power projects. |  |  | Sep 13, 2023 |  |
| ObvioHealth | ObvioHealth is a global digital health organization providing real-world digital clinical trials that deliver better data.Our mobile clinical study application allows for site-less trial design, allowing subjects to use their smartphones to participate in remote monitoring clinical trials from the comfort of their homes. For studies designed toinclude site visits, our application allows for continuous data collection in between visits to the clinic.By bringing the trial directly to the mobile device of each participant, our study team engages subjects daily using text message and chatbot features. This interaction allows for open communication and helps subjects feel involved during virtual clinical trials.The result: robust data collection, increased compliance, faster recruitment and improved time to completion.To assist with collecting real world data in clinical trials, our app can easy link to various health devices. They include Apple watches, Fitbits and activity trackers, along with Bluetooth scales, blood pressure monitors, and smart health apps.Participants can also use the app to schedule lab visits, or connect it with their PayPal account to receive compensation for decentralized clinical trials. And if the study team needs to talk with the participant during mobile clinical trials, the app allows for easy communication through chat or video.Visit Obviohealth.com to learn more about how our technology can help with observational clinical trials and virtual clinical trials. | $19.3M | Series B | Jun 08, 2021 |  |
| Global Growth | Fibronostics is a global diagnostics company, providing non-invasive, algorithmic diagnostics, and insights to detect and manage organ lesions caused by metabolic diseases. The company leverages artificial intelligence to screen and measure the progression and prognosis of liver & kidney disease as well as other chronic conditions. | $8M | Series A | Aug 24, 2020 |  |
| Lenddo | Lenddo is the world's first online community that empowers the emerging middle class to use online social connections to demonstrate their creditworthiness and access affordable, life-improving financial services. |  | Series B | Oct 14, 2015 |  |

4 of 4 investments shown.

## Co-investors
- [Alpine Meridian](https://shizune.co/investors/profile/alpine-meridian) — VC Fund, 1 deal together
- [Blumberg Capital](https://shizune.co/investors/profile/blumberg-capital) — VC Fund, 1 deal together
- Dedalus Group — VC Fund, 1 deal together
- [Elev8.VC](https://shizune.co/investors/profile/elevate-vc) — VC Fund, 1 deal together
- [Golden Gate Ventures](https://shizune.co/investors/profile/golden-gate-ventures) — VC Fund, 1 deal together
- [Life.SREDA](https://shizune.co/investors/profile/life-sreda) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Holdings invest in?

Holdings invests primarily in Health Care, Health Diagnostics and Solar startups, most often at Series B and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Holdings?

Public channels for Holdings include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Holdings?

The team at Holdings includes Arvind Tiku (Founder & Group Chairman). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co